These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32832247)
1. Cherenkov Luminescence Imaging for Assessment of Radioactive Plaque Position in Brachytherapy of Uveal Melanoma: An In Vivo Feasibility Study. Krohn J; Chen YC; Stabo-Eeg NO; Hamre B Transl Vis Sci Technol; 2020 Jun; 9(7):42. PubMed ID: 32832247 [TBL] [Abstract][Full Text] [Related]
2. Cerenkov Luminescence Imaging for Accurate Placement of Radioactive Plaques in Episcleral Brachytherapy of Intraocular Tumors. Axelsson J; Krohn J Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7362-8. PubMed ID: 26562170 [TBL] [Abstract][Full Text] [Related]
3. Brachytherapy With 15- Versus 20-mm Ruthenium 106 Plaques Without Verification of Plaque Position Is Associated With Local Tumor Recurrence and Death in Posterior Uveal Melanoma. Stålhammar G Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1125-1137. PubMed ID: 37433377 [TBL] [Abstract][Full Text] [Related]
6. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT; Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332 [TBL] [Abstract][Full Text] [Related]
7. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Toivonen P; Kivelä T Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837 [TBL] [Abstract][Full Text] [Related]
8. Early outcomes of uveal melanoma treated with intraoperative ultrasound guided brachytherapy using custom built plaques. Tann AW; Teh BS; Scarboro SB; Lewis GD; Bretana ME; Croft PC; Raizen Y; Butler EB; Kim RS; Chevez-Barrios P; Schefler AC Pract Radiat Oncol; 2017; 7(4):e275-e282. PubMed ID: 28377140 [TBL] [Abstract][Full Text] [Related]
9. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224 [TBL] [Abstract][Full Text] [Related]
11. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool. Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414 [TBL] [Abstract][Full Text] [Related]
12. Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma. Takiar V; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM Pract Radiat Oncol; 2014; 4(4):e189-94. PubMed ID: 25012839 [TBL] [Abstract][Full Text] [Related]
14. Episcleral plaque radiotherapy for uveal melanoma. Giblin ME; Shields JA; Augsburger JJ; Brady LW Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581 [TBL] [Abstract][Full Text] [Related]
15. A Modified Dummy Plaque for the Accurate Placement of Ruthenium-106 Plaques in Brachytherapy of Intraocular Tumours. Krohn J Ocul Oncol Pathol; 2015 Sep; 2(1):1-4. PubMed ID: 27172165 [TBL] [Abstract][Full Text] [Related]